Quantcast
Last updated on April 24, 2014 at 11:56 EDT

Latest Anxiolytics Stories

2012-02-22 16:46:00

DENVER, Feb. 22, 2012 /PRNewswire/ -- BIOFUEL ENERGY CORP. (NASDAQ: BIOF) announced today that it will be releasing its fourth quarter and year-end 2011 earnings on Thursday, March 1, 2012, after the market closes. The Company plans to host a conference call on Friday, March 2, 2012, beginning at 11:00 a.m. (EST) to discuss the results. To participate, please dial (800) 944-8766. The participant code for the call is 84358. This call will be available for phone playback for 30 days by...

2012-02-20 07:20:00

ATLANTA, Feb. 20, 2012 /PRNewswire/ -- The circumstances of Whitney Houston's demise have dominated headlines and search trends since news outlets first reported of her death. Her struggle with addiction was covered extensively by the media, and even discussed candidly by Houston herself during several high-profile interviews. Though toxicology reports needed for definitive answers have yet to be released, there has been no delay in rumors and speculation regarding what drugs may have been...

2012-02-16 14:57:15

Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures, according to a study sponsored by the National Institutes of Health and conducted by a Wayne State University School of Medicine researcher. The trial compared the effectiveness of two Federal Drug Administration-approved anti-seizure medications and how they are administered to patients suffering prolonged seizures before they arrive at hospitals. The Rapid...

2012-02-16 09:08:00

DETROIT, Feb. 16, 2012 /PRNewswire-USNewswire/ -- Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures, according to a study sponsored by the National Institutes of Health and conducted by a Wayne State University School of Medicine researcher. The trial compared the effectiveness of two Federal Drug Administration-approved anti-seizure medications and how they are administered to patients suffering prolonged seizures...

Auto-injectors Could Help Treat Prolonged Seizures
2012-02-16 11:41:02

New research, published in the New England Journal of Medicine, finds that when a person is experiencing a prolonged seizure, quick medical intervention is critical, becoming harder to stop the seizure with each passing minute, placing the patient at risk of severe brain damage and death. It is for this reason that paramedics are trained to administer anticonvulsive medications as soon as possible -- typically giving them intravenously before arriving at the hospital. But according to...

2012-01-23 10:09:20

Minuscule amounts of ethanol, the type of alcohol found in alcoholic beverages, can more than double the life span of a tiny worm known as Caenorhabditis elegans, which is used frequently as a model in aging studies, UCLA biochemists report. The scientists said they find their discovery difficult to explain. "This finding floored us – it's shocking," said Steven Clarke, a UCLA professor of chemistry and biochemistry and the senior author of the study, published Jan. 18 in the online...

2011-12-21 15:05:00

POINT RICHMOND, Calif., Dec. 21, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that it has received a $10 million milestone payment from Purdue Pharma L.P. in connection with the listing of Intermezzo formulation patents in the FDA Orange Book on December 15, 2011. The milestone payment was made under the terms of the agreement between Purdue and Transcept for the commercialization of Intermezzo in the United States. Purdue plans to launch...

2011-11-30 18:59:00

POINT RICHMOND, Calif., Nov. 30, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that it will host a conference call to discuss the exercise by Purdue of its option to commercialize Intermezzo® (zolpidem tartrate) sublingual tablet C-IV in the United States. Conference Call InformationDate: Thursday, December 1, 2011Time: 8:30 a.m. ETDial-in (U.S.): 877-638-4558Dial-in (International): 914-495-8537 A simultaneous web cast of...

2011-11-30 18:10:00

POINT RICHMOND, Calif., Nov. 30, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that Purdue has exercised its option to commercialize Intermezzo® in the United States. Purdue plans to launch Intermezzo in the second quarter of 2012 and to invest approximately $100 million to support sales and marketing during the first year of commercialization. On November 23, 2011, the U.S. Food Drug Administration (FDA) approved...

89709824
2011-11-24 12:18:16

On Wednesday, the U.S. Food and Drug Administration (FDA) approved medication specifically designed for those who wake up in the middle of the night and can't fall back to sleep. Transcept Pharmaceuticals Intermezzo is a lower-dose formulation of Zolpidem, which was first approved in the U.S. in 1992 and is better known as Ambien. "This is the first time the FDA has approved a drug for this condition," theFDA said in a statement. "Intermezzo should only be used when a person has at...